Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IMS Envisions e-DTC, Disease Management Products With TriZetto Merger

Executive Summary

IMS Health sees its merger with Internet start-up TriZetto as a way to offer web-based products to the pharmaceutical industry, including electronic direct-to-consumer advertising and online disease management programs.

You may also be interested in...



TriZetto Sees $90 Mil. Revenue Stream From Erisco, IMS Subsidiary

TriZetto could add around $90 mil. in incremental sales based on converting a portion of the customer base served by the Erisco subsidiary of IMS to a TriZetto application server provider contract, CEO Jeffery Margolis said during a May 18 teleconference.

TriZetto Sees $90 Mil. Revenue Stream From Erisco, IMS Subsidiary

TriZetto could add around $90 mil. in incremental sales based on converting a portion of the customer base served by the Erisco subsidiary of IMS to a TriZetto application server provider contract, CEO Jeffery Margolis said during a May 18 teleconference.

Cardinal.com Rx Market-Share Tracking Program In Beta Testing

Cardinal's "real time" market-share tracking information service is in beta testing, Chief Operating Officer John Kane told a March 24 conference unveiling the cardinal.com Internet site.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035816

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel